Symphogen has developed unique technologies for the controlled, reproducible production of highly characterized MAb mixtures manufactured in a single batch.
“The productivity and speed of stable cell line generation with the SUREtechnology Platform™ is playing a key role in quickly progressing our candidate into clinical development,” said Dr. Megan Ba...
Receive JSR Life Sciences news on your RSS reader.